DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y.
Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.
Antimicrob Agents Chemother 2010;
54 (5) 2010-2016
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.